PubMed HealthSearch

PubMed · 4209062

Doxepin versus amitriptyline in depression: a sequential double-blind study.

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Grof, B Saxena, R Cantor, L Daigle, D Hetherington, T Haines. 1974. Doxepin versus amitriptyline in depression: a sequential double-blind study.. https://pubmed.ncbi.nlm.nih.gov/4209062/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes.

The purpose of this review is to present relatively detailed information on the characteristics of tricyclic antidepressants, mainly amitriptyline hydrochloride and doxepin hydrochloride, for use as an integral part of the safe and effective management of fibromyalgia and, to a lesser extent, other chronic pain syndromes. Data sources include MEDLINE searches in English, relevant reference books and textbooks, my personal database and library, as well as personal clinical experience. I discuss these data with regard to the pharmacologic characteristics, mechanisms of action, adverse effects, and precautions involved with the use of tricyclic antidepressants. Additional information is given on drug selection and dosage titration. Much emphasis is placed on the fact that while tricyclic antidepressants play a major role in the management of fibromyalgia and other chronic pain syndromes, lifestyle alterations (eg. physical reconditioning and exercise), as well as behavior modification, are also vital to a successful outcome in management.

Amitriptyline

Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants.

Psychotropic agents modify the release of histamine and serotonin from rat peritoneal mast cells induced by compound 48/80. Some antidepressants, such as clomipramine and fluoxetine (10(-8) - 10(-5) mol/l), increase the percentage of released serotonin in the incubation medium but have no effect on histamine release. In contrast, amitriptyline (10(-4) mol/l) inhibits the secretion of histamine and permits that of serotonin. The varying effects of antidepressants on the secretion of histamine and serotonin could be explained either by a differential mechanism of secretion of both amines from mast cells or by a selective effect of drugs on the reuptake of serotonin into mast cells after stimulation by compound 48/80. These hypotheses were further investigated in our present study on rat peritoneal mast cells. Our findings suggest that antidepressants influence the secretion and the reuptake process of amines used. Their effects depend on the concentration of the drug. At lower concentrations, antidepressants (amitriptyline, doxepine and clomipramine) produce no effect on the secretion of the amines whereas at higher concentrations ( > 10(-5) mol/l), they inhibit the release. Additionally, mast cells are capable of removing released serotonin from the incubation medium. Serotonin uptake is an active process which increases with the time of incubation with exogenous serotonin and depends on the presence of extracellular Ca2+ and on the temperature of the medium. Preincubation of mast cells with antidepressants inhibits the reuptake of serotonin into mast cells and thus increases the concentration of serotonin in the incubation medium. Since the reuptake of serotonin is a relatively slow process, the elevation of serotonin in the medium is evident only after longer times of incubation.

Amitriptyline